ReP USP - Resultado da busca

Artigo de periodico
Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis (2018)
Pereira, Camila A.; Carneiro, Fernando Silva; Matsumoto, Takayuki; Passaglia, Rita de Cássia Aleixo Tostes
Source: Basic and Clinical Pharmacology and Toxicology. Unidade: FMRP
Subjects: DIABETES MELLITUS, FÁRMACOS, ENDOTÉLIO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Camila A. et al. Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis. Basic and Clinical Pharmacology and Toxicology, v. 123, n. 5, p. 523-538, 2018Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13054. Acesso em: 16 nov. 2024.
APA
Pereira, C. A., Carneiro, F. S., Matsumoto, T., & Passaglia, R. de C. A. T. (2018). Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis. Basic and Clinical Pharmacology and Toxicology, 123( 5), 523-538. doi:10.1111/bcpt.13054
NLM
Pereira CA, Carneiro FS, Matsumoto T, Passaglia R de CAT. Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis [Internet]. Basic and Clinical Pharmacology and Toxicology. 2018 ; 123( 5): 523-538.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcpt.13054
Vancouver
Pereira CA, Carneiro FS, Matsumoto T, Passaglia R de CAT. Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis [Internet]. Basic and Clinical Pharmacology and Toxicology. 2018 ; 123( 5): 523-538.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcpt.13054
Artigo de periodico
High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity ? (2016)
Lima, Victor L.; Giachini, Fernanda R.; Matsumoto, Takayuki; Li, Weiguo; Bressan, Alecsander F. M.; Chawla, Dhruv; Webb, R. Clinton; Ergul, Adviye; Tostes, Rita de Cássia Aleixo
Source: Clinical Science. Unidade: FMRP
Subjects: ARTÉRIAS CEREBRAIS, HIPERLIPIDEMIA, PROTEÍNAS QUINASES, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Victor L. et al. High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity ?. Clinical Science, v. 130, n. 11, p. 871-881, 2016Tradução . . Disponível em: https://doi.org/10.1042/CS20150777. Acesso em: 16 nov. 2024.
APA
Lima, V. L., Giachini, F. R., Matsumoto, T., Li, W., Bressan, A. F. M., Chawla, D., et al. (2016). High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity ? Clinical Science, 130( 11), 871-881. doi:10.1042/CS20150777
NLM
Lima VL, Giachini FR, Matsumoto T, Li W, Bressan AFM, Chawla D, Webb RC, Ergul A, Tostes R de CA. High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity ? [Internet]. Clinical Science. 2016 ; 130( 11): 871-881.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1042/CS20150777
Vancouver
Lima VL, Giachini FR, Matsumoto T, Li W, Bressan AFM, Chawla D, Webb RC, Ergul A, Tostes R de CA. High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity ? [Internet]. Clinical Science. 2016 ; 130( 11): 871-881.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1042/CS20150777
Artigo de periodico
Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes (2015)
Matsumoto, Takayuki; Goulopoulou, Styliani; Taguchi, Kumiko; Tostes, Rita de Cássia Aleixo; Kobayashi, Tsuneo
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ENDOTÉLIO VASCULAR, ADENOSINA, HIPERTENSÃO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUMOTO, Takayuki et al. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, v. 172, n. 16, p. 3980-4001, 2015Tradução . . Disponível em: https://doi.org/10.1111/bph.13205. Acesso em: 16 nov. 2024.
APA
Matsumoto, T., Goulopoulou, S., Taguchi, K., Tostes, R. de C. A., & Kobayashi, T. (2015). Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, 172( 16), 3980-4001. doi:10.1111/bph.13205
NLM
Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bph.13205
Vancouver
Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bph.13205
Artigo de periodico
Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation (2015)
Ferreira, Nathanne S.; Cau, Stefany B. A; Silva, Marcondes A. B.; Manzato, Carla Pavan; Mestriner, Fabiola Leslie Antunes Cardoso; Matsumoto, Takayuki; Carneiro, Fernando Silva; Passaglia, Rita de Cassia Aleixo Tostes
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ALDOSTERONA, CÉLULAS ENDOTELIAIS, DIABETES MELLITUS, RECEPTORES HORMONAIS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Nathanne S. et al. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Frontiers in Pharmacology, v. 6, 2015Tradução . . Disponível em: https://doi.org/10.3389/fphar.2015.00034. Acesso em: 16 nov. 2024.
APA
Ferreira, N. S., Cau, S. B. A., Silva, M. A. B., Manzato, C. P., Mestriner, F. L. A. C., Matsumoto, T., et al. (2015). Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Frontiers in Pharmacology, 6. doi:10.3389/fphar.2015.00034
NLM
Ferreira NS, Cau SBA, Silva MAB, Manzato CP, Mestriner FLAC, Matsumoto T, Carneiro FS, Passaglia R de CAT. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation [Internet]. Frontiers in Pharmacology. 2015 ; 6[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2015.00034
Vancouver
Ferreira NS, Cau SBA, Silva MAB, Manzato CP, Mestriner FLAC, Matsumoto T, Carneiro FS, Passaglia R de CAT. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation [Internet]. Frontiers in Pharmacology. 2015 ; 6[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2015.00034

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation